Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Evaluation of the clinical ben...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients - Permal study sub-set analysis
Show other versions (3)
Bibliographic Details
Main Authors:
Debruyne, F
,
Boyle, P
,
Vela-Navarrete, R
,
Da Silva, F
,
Teillac, P
,
Perrin, P
,
Hamdy, F
,
Raynaud, J
Format:
Conference item
Published:
2004
Holdings
Description
Other Versions (3)
Similar Items
Staff View
Similar Items
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis.
by: Debruyne, F, et al.
Published: (2004)
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].
by: Debruyne, F, et al.
Published: (2004)
Evaluation of the clinical benefit of permixon® and tamsulosin in severe BPH patients - PERMAL study subset analysis
by: Debruyne, F, et al.
Published: (2004)
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study
by: Debruyne, F, et al.
Published: (2002)
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
by: Debruyne, F, et al.
Published: (2002)